H. A. Burris

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Gabriel N. Hortobágyi, Salomon M. Stemmer, H. A. Burris et al. · Annals of Oncology · 2018 · 839 citations · Full text

Pooled analysis of diarrhea events in patients with cancer treated with lapatinib

John Crown, H. A. Burris, Frances M. Boyle et al. · Breast Cancer Research and Treatment · 2008 · 97 citations

Gastrointestinal Oncology, Medicine, Cancer Management +8

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors

Mace L. Rothenberg, A. Sharma, Geoffrey R. Weiss et al. · Annals of Oncology · 1998 · 76 citations

Malignant Disease, Medicine, Clinical Trials +8

Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement.

Andrés Cervantes, María Alsina, Josep Tabernero et al. · Journal of Clinical Oncology · 2011 · 54 citations

Solid Tumors, Liver Involvement, Novel Rnai Therapeutic +17

A first-in-human phase I study of BKM120, an oral pan-class I PI3K inhibitor, in patients (pts) with advanced solid tumors.

José Baselga, Maja J. De Jonge, Jordi Rodón et al. · Journal of Clinical Oncology · 2010 · 53 citations

Pathology, Pi3k Inhibitor, Pharmacotherapy +16